JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
Product Usage: This PRODUCT IS INTENDED AS A RESEARCH CHEMICAL ONLY. This designation is allowed to use of research chemicals strictly for in vitro testing and laboratory experimentation only. All product information available on this website for educational purpose only. Bodily introduction of any kind into humans and animals is strictly forbidden by law. This product should only be handled by licenced qualified professionals. This product is not a drug, food, or cosmetic and may not be misbranded, misused as a drug, food and cosmetic.
FREE Shipping for orders over $200
For this product you will need: BACTERIOSTATIC WATER For reconstitution.
Ipamorelin is a synthetic pentapeptide in the GHRP family. It is a ghrelin receptor agonist and has been studied for the effects of its antagonism of anterior pituitary somatotrope action in the regulation of pulsatile release growth hormone in laboratory conditions.
Ipamorelin is known as a selective growth hormone secretagogue, focusing on GH out of all the other pituitary hormones such as cortisol, follicle-stimulating hormone, luteinizing hormone and adrenocorticotropic hormone in in-vitro and animal studies. Because of its receptor specificity and signal kinetics, it is a molecule of study for the laboratory. Ipamorelin for sale on our website is intended for research purposes only.
From Pubchem
IUPAC Name: (2S)-6-amino-2-[[(2R)-2-[[(2R)-2-[[(2S)-2-[(2-amino-2-methylpropanoyl)amino]-3-(1H-imidazol-5-yl)propanoyl]amino]-3-naphthalen-2-ylpropanoyl]amino]-3-phenylpropanoyl]amino]hexanamideSynonym: Aib-His-2Nal-Phe-Lys-NH2Molecular Formula: C38H49N9O5Molecular Weight: 711.9 g/molSequence: XHXFKCAS Number: 170851-70-4PubChem CID: 9831659
Ipamorelin is a synthetic pentapeptide that functions as a selective agonist of the ghrelin receptor and a growth hormone secretagogue. Under controlled laboratory conditions, it has been studied for its involvement in growth hormone–associated signaling pathways and its relevance to bone metabolism and tissue turnover research. Experimental investigations have examined ipamorelin’s interaction with receptor-mediated mechanisms and downstream growth factor–related signaling pathways [1].
In vitro experimental studies have explored the role of ipamorelin in musculoskeletal cell signaling and tissue remodeling. Research has focused on its interaction with growth hormone secretagogue receptors and downstream pathways such as IGF-1–associated signaling, myoblast proliferation, and differentiation-related molecular markers. Ipamorelin has also been evaluated for its receptor selectivity and limited interaction with other pituitary hormone pathways in controlled research settings [2].
Laboratory-based investigations have assessed ipamorelin within glucose-related cellular signaling frameworks. Studies have examined its interaction with insulin-associated pathways, receptor-binding dynamics, intracellular calcium signaling, and adrenergic pathway involvement. These evaluations are conducted exclusively within experimental models and do not imply clinical or therapeutic application [3].
Ipamorelin is a synthetic growth hormone secretagogue with specificity for ghrelin receptors. Its receptor-mediated signaling activity continues to be investigated in laboratory research, including pathways related to growth hormone signaling, musculoskeletal systems, and glucose regulation. Research involving IGF-1–associated and bone-related pathways remains ongoing. Ipamorelin supplied by Element CRP is intended strictly for research and educational use and is available only to qualified and licensed investigators.
Ipamorelin is a synthetic pentapeptide growth hormone secretagogue with a structure optimised for selective engagement of the ghrelin receptor (GHSR-1a) without cross-reactivity at unrelated GPCRs. Its compact peptide architecture provides reliable stability across in vitro buffer systems and supports reproducible cell-based receptor pharmacology characterisation.
Cell-based assay research with Ipamorelin examines selective GHSR-1a agonist activity using receptor-transfected HEK293 and CHO-K1 cell lines, with Gaq/PLC coupling and intracellular calcium mobilisation as primary functional readouts. Comparative selectivity profiling against related growth hormone secretagogues maps its distinct pharmacological signature in receptor pharmacology research.
Element CRP supplies this product at 5mg per vial. USA-manufactured via solid-phase peptide synthesis and verified at 99%+ purity by HPLC and Mass Spectrometry. Reconstitution with bacteriostatic water required. Store lyophilised at -20°C; stable for 24 months.
WARNING: For research use only. Not for human or animal consumption. Not intended to diagnose, treat, cure, or prevent any disease. For use by qualified research professionals only.
Forgot password?
Country: United States (US-only registration)
All products on this site are for Research, Development use only. Products are Not for Human consumption of any kind. The statements made within this website have not been evaluated by the US Food and Drug Administration. The statements and the products of this company are not intended to diagnose, treat, cure or prevent any disease.
Element CRP is a chemical supplier. Element CRP is not a compounding pharmacy or chemical compounding facility as defined under 503A of the Federal Food, Drug, and Cosmetic act. Element CRP is not an outsourcing facility as defined under 503B of the Federal Food, Drug, and Cosmetic act.
